Physician profile
Ashley Macy
NPI 1184278699
$1,552.85
in general payments reported to CMS, 2019-2025
18 companies · $737 in 2025
The $737 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $155 · 2023: $197 · 2024: $463 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $477.14 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Cvrx, INC. | $194.99 | 2024-2025 | Barostim Neo System |
| Amgen INC. | $174.77 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $135.02 | 2025 | |
| Merck Sharp & Dohme LLC | $77.39 | 2024-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $66.65 | 2024-2025 | Amvuttra |
| United Therapeutics Corporation | $64.66 | 2024-2025 | Tyvaso, Tyvaso |
| E.R. Squibb & Sons, L.L.C. | $60.14 | 2024-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.23 | 2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.63 | 2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $38.43 | 2025 | Wainua |
| Kiniksa Pharmaceuticals International, Plc | $36.40 | 2024 | Arcalyst |
| Philips North America LLC | $32.91 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Lemaitre Vascular, INC. | $32.50 | 2025 | Hydro Lemaitre Valvulotome |
| Novo Nordisk INC | $19.21 | 2025 | Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $16.90 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.67 | 2025 | |
| Convatec INC. | $14.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Macy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.